New E700,000 initiative launched to tackle cancer in children in the developing world

November 30, 2005

14 innovative projects in Bangladesh, Egypt, Honduras, Morocco, the Philippines, Senegal, Tanzania, Ukraine, Venezuela, and Vietnam will receive up to E50,000 each to improve cancer care for children, announce The Lancet Oncology and the International Union Against Cancer (UICC) today (Thursday December 1, 2005).

An estimated 160,000 children around the world are diagnosed with cancer every year. However, the exact number of new cases is probably much higher because these data are not recorded in many countries. Governments in the developing world cannot afford to make childhood cancer a priority in healthcare, and external donations and aid programmes are rarely earmarked for this purpose.

"And yet 80% of all children with cancer live in the developing world", remarks Isabel Mortara, Executive Director of the UICC in Geneva. "In the developed world, overall childhood cancer survival rates are around 75%, but in the developing world almost two-thirds of children with cancer die. Many children are never diagnosed at all, many are diagnosed too late, and when a diagnosis is made the treatment options may be limited. Relatively little money could, however, make important inroads into this situation."

The 14 projects will receive funding as part of the launch of the UICC's World Cancer Campaign. The My Child Matters initiative aims to improve dissemination of information about cancer in children, to improve early diagnosis and access to care, and to strengthen support for children with cancer and their families in the developing world. The projects encompass a huge range of ideas, from provision of psychosocial and nutritional support to the setting up of satellite clinics through the internet to try to make treatment more accessible.

In total, 58 applications were received. "The standard of the proposals was extremely high; it is indeed a pity that we cannot fund them all", notes Franco Cavalli, Chair of the UICC Childhood Cancer Campaign Advisory Committee, the group that selected the recipients. He adds that the projects were chosen for their feasibility, potential benefits, accountability, and sustainability, and the "possibility of them serving as models for other countries".
Jose Julio Divino

Note to editors
Details of the selected projects have been announced jointly by the The Lancet Oncology and UICC, and can be found at


Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to